Zero Candida Technologies (TSXV:ZCT) Other Current Receivables: C$0.13 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:ZCT Zero Candida Technologies Inc TSXV:ZCT
14 GF Score
Price C$0.16
! 1 Warning Sign
View Full Analysis

What is Zero Candida Technologies Other Current Receivables?

Zero Candida Technologies TSXV:ZCT 14 Other Current Receivables is C$0.13 Mil as of Dec. 2025. GuruFocus rates TSXV:ZCT with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Zero Candida Technologies's Other Current Receivables for the quarter that ended in Dec. 2025 was C$0.13 Mil.

Zero Candida Technologies's quarterly Other Current Receivables declined from Jun. 2025 (C$0.06 Mil) to Sep. 2025 (C$0.06 Mil) but then increased from Sep. 2025 (C$0.06 Mil) to Dec. 2025 (C$0.13 Mil).

Zero Candida Technologies's annual Other Current Receivables stayed the same from Jul. 2023 (C$0.00 Mil) to Jul. 2024 (C$0.00 Mil) but then increased from Jul. 2024 (C$0.00 Mil) to Dec. 2025 (C$0.13 Mil).

Zero Candida Technologies Other Current Receivables Related Terms

Zero Candida Technologies Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Zero Candida Technologies's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zero Candida Technologies Other Current Receivables Chart

Zero Candida Technologies Annual Data
Trend Jul23 Jul24 Dec25
Other Current Receivables
0.00 0.00 0.13

Zero Candida Technologies Quarterly Data
Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Mar25 Jun25 Sep25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.08 0.06 0.06 0.13
TSXV:ZCT
14GF Score
Zero Candida Technologies Inc TSXV:ZCT
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zero Candida Technologies Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of C$0.13 Mil mean?
Zero Candida Technologies (TSXV:ZCT) has a Other Current Receivables of C$0.13 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Zero Candida Technologies and its competitors.
Is Zero Candida Technologies' Other Current Receivables too high?
Zero Candida Technologies' current Other Current Receivables is C$0.13 Mil. Overall, Zero Candida Technologies has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zero Candida Technologies' Other Current Receivables compare to ABT and SYK?
Zero Candida Technologies' Other Current Receivables of C$0.13 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Zero Candida Technologies and its competitors. Zero Candida Technologies's current Other Current Receivables is C$0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zero Candida Technologies stock overvalued right now?
Zero Candida Technologies (TSXV:ZCT) has a current Other Current Receivables of C$0.13 Mil. The current Other Current Receivables is C$0.13 Mil. Zero Candida Technologies' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Zero Candida Technologies (TSXV:ZCT), the current Other Current Receivables is C$0.13 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zero Candida Technologies Business Description

Address 666 Burrard Street, Suite 500, Vancouver, BC, CAN, V6C 3P6
Zero Candida Technologies Inc is engaged in providing female healthcare solutions. The company technology uses a controlled Blue Light to destroy the fungus at record speed and without side effects. It focused on developing and commercializing several patents and patent applications concerning an AI smart tampon-like device, designed to treat Candidiasis and transfer medical information via Wi-Fi to the doctor.
14GF Score

Get the complete analysis for TSXV:ZCT

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.16
Price